Company signals · MedTech
Abbott
3 signals in the current window, with MitchelLake's leadership read on each.
Last updated
Market context: Against a Talent Market Index of 111.1 (Hot) (up 5.2 month-on-month), Americas is at rising (+6.3pts) on signal share.
Abbott: 2 signals in the last 90 days — above the MedTech median of 1 across 21 tracked companies; 0.1% of MitchelLake's Americas signal flow; 3 tracked across 83 days.
Signals at Abbott
Product Launch
EMEAAbbott launched CE-marked dual glucose-ketone Libre Duo sensors in Europe through expanded partnership with MiniMed, representing first-of-its-kind dual-analyte diabetes technology
Leadership read: Product momentum tends to widen medtech product and commercial leadership bench strength.
curated · 2026-06-14 · context →
Ma Activity
AmericasAbbott completed acquisition of Exact Sciences, establishing itself as a leader in the fast-growing oncology diagnostics market
Leadership read: Consolidation of this kind shifts demand toward integration and transformation leadership bench strength in medtech.
curated · 2026-04-16 · context →
Ma Activity
AmericasAbbott completes acquisition of Exact Sciences, establishing Abbott as a leader in cancer screening and diagnostics segments
Leadership read: Consolidation of this kind shifts demand toward integration and transformation leadership bench strength in medtech.
curated · 2026-03-23 · context →
MitchelLake in this thematic
More signals across MedTech
Ma Activity · Americas
Medtronic →Medtronic completed a $550M acquisition of Scientia Vascular, expanding its vascular intervention and treatment capabilities
Ma Activity · Americas
Analog Devices →In talks to acquire Empower Semiconductor for $1.5 billion, focusing on AI chip power management
Ma Activity · Americas
Boston Scientific →Boston Scientific invested $1.5bn to acquire a 34% equity stake in MiRus, an implants and procedural solutions developer
Ma Activity · Americas
McKesson →Apollo acquiring minority stake in McKesson's medical-surgical solutions business for $1.25bn, valuing the division at $13bn
Ma Activity · Americas
QuidelOrtho Corporation →QuidelOrtho Corporation completed acquisition of LEX Diagnostics, expanding into point-of-care molecular diagnostics with ultra-fast PCR platform delivering results in ~10 minutes
Intelligence powered by Autonodal ↗